BIOCUBE PHARMACEUTICAL PRIVATE LIMITED
BIOCUBE PHARMACEUTICAL PRIVATE LIMITED is a DELHI based PRIVATE LIMITED company, Registered at dated 19-JUL-2022 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of BIOCUBE PHARMACEUTICAL PRIVATE LIMITED is U24299DL2022PTC401939 and registration number is 401939.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies DELHI India. Authorized share capital of BIOCUBE PHARMACEUTICAL PRIVATE LIMITED is Rs. 1000000 and its paid up capital is Rs. 100000. It aspire to serve in MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
BIOCUBE PHARMACEUTICAL PRIVATE LIMITED has 2 directors SHARDA KHANNA, SMRITI KUMARI,
The registered Email address of BIOCUBE PHARMACEUTICAL PRIVATE LIMITED is biocubepharmaceutical@gmail.com and its registered address is 284/2 GROUND FLOOR SAIDULAJAB NEAR DELHI SOUTH WEST DELHI DL 110030 IN DELHI DELHI india 110030.
The current status of BIOCUBE PHARMACEUTICAL PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
BIOCUBE PHARMACEUTICAL PRIVATE LIMITED
DELHI
ACTIVE
MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS
U24299DL2022PTC401939
19-JUL-2022
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1000000
100000
CONTACT DETAILS
110030
INDIA
284/2 GROUND FLOOR SAIDULAJAB NEAR DELHI SOUTH WEST DELHI DL 110030 IN
biocubepharmaceutical@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
09677506 | SHARDA KHANNA | Director | 19/07/2022 |
09677507 | SMRITI KUMARI | Director | 19/07/2022 |
Details Updated by Companies
Quick Links
- All Registered company of DELHI
- Company Registered in DELHI
- All Registered company of SOUTH DELHI in DELHI
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.